Exendin-4 analogs in insulinoma theranostics.
Theodorus J P JansenSanne A M van LithMarti BossMaarten BromLieke JoostenMartin BéhéMijke BuitingaMartin GotthardtPublished in: Journal of labelled compounds & radiopharmaceuticals (2020)
Insulinomas, neuroendocrine tumors arising from pancreatic beta cells, often show overexpression of the glucagon-like peptide-1 receptor. Therefore, imaging with glucagon-like peptide analog exendin-4 can be used for diagnosis and preoperative localization. This review presents an overview of the development and clinical implementation of exendin-based tracers for nuclear imaging, and the potential use of exendin-4 based tracers for optical imaging and therapeutic applications such as peptide receptor radionuclide therapy or targeted photodynamic therapy.